‘Backrooms’ scares up $81 million opening, while ‘Obsession’ continues to grow

Horror films with very small budgets dominated the late-May box office, with 'Backrooms' opening at $81 million and 'Obsession' continuing to grow, while 'The Mandalorian & Grogu' fell to third place in its second weekend at $25 million. The result underscores strong consumer demand for low-cost horror content and relative weakness for the latest Star Wars release. The broader read-through is positive for exhibitors and horror-content economics, but the article is unlikely to move markets materially.

Analysis

This is less a one-off box-office surprise than a signal that audience discovery is becoming algorithmic and talent is being re-priced. Low-budget genre content with built-in shareability can now monetize faster than legacy franchise IP, which pressures mid-budget studio slates and makes opening-weekend forecasting less reliable. The second-order effect is that marketing efficiency, not brand ownership, is increasingly the scarce resource; studios that can cheaply manufacture cultural momentum will outperform those relying on inherited fandom.

For incumbents, the damage is not just to one tentpole but to the economics of the entire release calendar. If consumers are willing to allocate theatrical spend to cheaper, fresher concepts, the risk is a demand bifurcation: premium event films still work, but the middle becomes more fragile, which compresses return thresholds for larger-budget productions. That should force studios and exhibitors to lean harder into shorter windows, more dynamic pricing, and tighter inventory management around screens and promo spend.

The contrarian read is that this is not necessarily bearish for theatrical itself; it may actually be a positive for overall attendance because novelty is beating familiarity. The market may be underestimating the optionality embedded in creator-led IP pipelines, especially where social-first distribution lowers customer acquisition costs. The key risk is imitation: once every studio floods the market with micro-budget horror, the edge compresses quickly, and the trade becomes a capacity/algorithm war rather than a durable genre premium.

Key Decisions for Investors

• Long AMC / short a basket of legacy franchise-exposed studio economics via DIS or PARA on a 1-3 month horizon: thesis is that theaters benefit from higher traffic and more diverse supply, while legacy IP-dependent studios face weaker pricing power and more volatile slate economics. Size modestly; the trade is about relative margin resilience, not absolute box-office upside.
• Buy calls on META or GOOG with 3-6 month tenor as a second-order beneficiary: creator-led films validate the value of social distribution and algorithmic discovery, which should keep ad CPMs and content engagement elevated for platforms that can surface low-cost viral IP.
• Pair long small/mid-cap exhibition or specialty-distribution exposure against short traditional studio exposure if liquidity permits: the market is likely to overpay for perceived 'winner-takes-all' franchise moats while underpricing the recurring economics of audience aggregation and content discovery.
• Avoid chasing the headline as a long in broad media beta; instead wait 2-4 weeks for confirmation in box-office comps and release-date revisions before adding risk. If subsequent micro-budget titles repeat the pattern, the move becomes a genuine slate-reset catalyst; if not, the current enthusiasm likely fades quickly.